Rodriguez-Acuña Rafael, Mayoral Eduardo, Aguilar-Diosdado Manuel, Rave Reyes, Oyarzabal Beatriz, Lama Carmen, Carriazo Ana, Martinez-Brocca Maria Asuncion
Andalusian Public Foundation Progress and Health, Seville, Spain.
Comprehensive Healthcare Plan for Diabetes, Regional Ministry of Health and Families of Andalusia, Government of Andalusia, Seville, Spain.
BMJ Open Diabetes Res Care. 2020 Oct;8(1). doi: 10.1136/bmjdrc-2020-001622.
Diabetic retinopathy (DR) is a preventable cause of vision loss and blindness worldwide. We aim at analyzing the impact of a population-based screening program of DR using retinal photography with remote reading in terms of population coverage, diagnosis of asymptomatic DR and impact on visual disability, in the region of Andalusia, Spain, in the period 2005-2019.
Descriptive study. Sociodemographic and clinical features included in the Andalusian program for early detection of diabetic retinopathy (APDR) were analyzed. Population coverage, annual incidence of DR, and DR severity gradation were analyzed. Estimated data on prevalence and incidence of legal blindness due to DR were included.
407 762 patients with at least one successful DR examination during the study period were included. Most of the performed retinographies (784 584, 84.3%) were 'non-pathological.' Asymptomatic DR was detected in 52 748 (5.9%) retinographies, most of them (94.2%) being classified as 'mild to moderate non-proliferative DR.' DR was detected in 44 815 patients, while sight-threatening DR (STDR) in 6256 patients; cumulative incidence of DR was 11.0% and STDR was 1.5%, as DR and STDR was detected in 44 815 and 6256 patients, respectively. Annual incidence risk per patient recruitment year progressively decreased from 22.0% by January 2005 to 3.2% by June 2019.
Implementation of a long-term population-based screening program for early detection of DR is technically feasible and clinically viable. Thus, after 15 years of existence, the program has enabled the screening of the vast majority of the target population allowing the optimization of healthcare resources and the identification of asymptomatic DR.
糖尿病视网膜病变(DR)是全球范围内可预防的视力丧失和失明的原因。我们旨在分析在2005 - 2019年期间,西班牙安达卢西亚地区基于人群的糖尿病视网膜病变筛查项目(使用视网膜摄影和远程阅片)在人群覆盖、无症状糖尿病视网膜病变的诊断以及对视力残疾的影响方面的作用。
描述性研究。分析了安达卢西亚糖尿病视网膜病变早期检测项目(APDR)中包含的社会人口统计学和临床特征。分析了人群覆盖情况、糖尿病视网膜病变的年发病率以及糖尿病视网膜病变严重程度分级。纳入了因糖尿病视网膜病变导致法定失明的患病率和发病率的估计数据。
纳入了在研究期间至少有一次成功的糖尿病视网膜病变检查的407762名患者。大多数进行的视网膜造影(784584次,84.3%)为“非病理性”。在52748次(5.9%)视网膜造影中检测到无症状糖尿病视网膜病变,其中大多数(94.2%)被分类为“轻度至中度非增殖性糖尿病视网膜病变”。在44815名患者中检测到糖尿病视网膜病变,而在6256名患者中检测到威胁视力的糖尿病视网膜病变(STDR);糖尿病视网膜病变的累积发病率为11.0%,STDR为1.5%,因为分别在44815名和6256名患者中检测到糖尿病视网膜病变和STDR。每位患者入组年份的年发病风险从2005年1月的22.0%逐渐降至2019年6月的3.2%。
实施基于人群的长期糖尿病视网膜病变早期检测筛查项目在技术上是可行的,临床上也是可行的。因此,在该项目实施15年后,已能够对绝大多数目标人群进行筛查,从而优化医疗资源并识别无症状糖尿病视网膜病变。